HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

lobeglitazone

putative antidiabetic agent for type 2 diabetes; structure in first source
Also Known As:
CKD 501; CKD-501; CKD501
Networked: 9 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Jang, Hak Chul: 3 articles (12/2015 - 01/2014)
2. Kim, Chin: 3 articles (09/2015 - 07/2014)
3. Kim, Dal-Hyun: 3 articles (07/2014 - 11/2011)
4. Ko, Kyung Soo: 2 articles (12/2015 - 01/2014)
5. Park, Yong Soo: 2 articles (12/2015 - 01/2014)
6. Park, Jeong Hyun: 2 articles (12/2015 - 01/2014)
7. Kim, Doo Man: 2 articles (12/2015 - 01/2014)
8. Choi, Dong Seop: 2 articles (12/2015 - 01/2014)
9. Chung, Choon Hee: 2 articles (12/2015 - 01/2014)
10. Woo, Jeong-Taek: 2 articles (12/2015 - 01/2014)

Related Diseases

1. Type 2 Diabetes Mellitus (MODY)
2. Insulin Resistance
3. Atherosclerosis
4. Weight Gain
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. Peroxisome Proliferator-Activated Receptors (PPAR)
2. rosiglitazone (Avandia)
3. pioglitazone (Actos)
4. PPAR gamma
5. Amlodipine (Norvasc)